LABSYSTEMS DIAGNOSTICS

Labsystems Diagnostics Oy develops, manufactures, markets and sells diagnostic tests globally for clinical laboratory use, home use and doctors’ offices. It offers a complete range of newborn screening systems and tests, ranging from fully-integrated robotic platforms to systems based on fluorescence detection and variou ...
Productos Covid-19
Close

Covid-19 LABSYSTEMS DIAGNOSTICS

Laboratorio clínico

COVID-19 IgM, IgG Test
Biocard COVID-19 IgM, IgG Test

The Biocard COVID-19 IgM, IgG Test is the first reliable and rapid antibody based test for the qualitative detection of IgM and IgG antibodies against COVID-19 in human serum, plasma, and whole blood. The test is based on the lateral flow immunochromatographic principle and delivers results in less than 10 minutes.
Mas detalles

Respiratory Multiplex RT-PCR Kit
Respiratory Multiplex RT-PCR Kit

The Respiratory Multiplex RT-PCR Kit is intended for the simultaneous detection of SARS- CoV-2, Influenza A, Influenza B, and RSV A/B by targeting ORF1ab, M, HA & N genes, respectively, in addition to internal control gene. It has a low virus load detection of 1.25 to 10 copies/µl and allows the use of extracted RNA samples from the entire respiratory tract.
Mas detalles
Facebook Twitter Google+ Linked in

Respiratory Multiplex RT-PCR Kit

Modelo: Respiratory Multiplex RT-PCR Kit
Respiratory Multiplex RT-PCR Kit

Descripción:

The Respiratory Multiplex RT-PCR Kit is intended for the simultaneous detection of SARS- CoV-2, Influenza A, Influenza B, and RSV A/B by targeting ORF1ab, M, HA & N genes, respectively, in addition to internal control gene. It has a low virus load detection of 1.
Más info

Descripción completa Características: Especificaciones:

Descripción

The Respiratory Multiplex RT-PCR Kit is intended for the simultaneous detection of SARS- CoV-2, Influenza A, Influenza B, and RSV A/B by targeting ORF1ab, M, HA & N genes, respectively, in addition to internal control gene. It has a low virus load detection of 1.25 to 10 copies/µl and allows the use of extracted RNA samples from the entire respiratory tract.

Características:

• Simultaneous detection of SARS- CoV-2, Influenza A, Influenza B, and RSV A/B by targeting ORF1ab, M, HA & N genes, respectively, in addition to internal control gene
• Low virus load detection: 1.25 to 10 copies/µl
• Extracted RNA samples from entire respiratory tract can be used
• Compatible with multiple RT-PCR instruments

Especificaciones:

• Highly Specific: No detectable cross reactivity with any of the human coronavirus strains and other respiratory pathogens
• Utmost Sensitivity: Capable of detecting multiple SARS -CoV-2 variants (including UK, South African, Japanese, Indian, and others), besides influenza (A/B) and RSV A/B from RNA samples with very low virus loads
• Timesaving Approach: Processing time is approximately 1.5 hours
• Certified Quality: CE IVD marked reliable quality from Northern Europe
• Compatible with most of the real-time PCR Instruments with a minimum of five measurement channels (FAM, HEX, Texas Red, CY5.5 & CY5)
• Developed and validated on CFX96 from Bio-Rad
• RNA Isolation: kit is compatible with several commercially qualified RNA extraction kits
• Shelf life: 12 months Solicite información

Enviar un mensaje al proveedor

* Información requerida
* Email:
Para
LABSYSTEMS DIAGNOSTICS ()
* Mensaje

Derecho de autor © 2000-2021 TradeMed.com. Todos los derechos reservados. | Términos y condiciones